Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(337)
•••
Comment by jayjay2020on Apr 23, 2019 2:59pm
65 Views
Post# 29660831

RE:RE:RE:RE:RE:RE:Know the facts.

RE:RE:RE:RE:RE:RE:Know the facts.
SoilStory wrote: That’s not the only Germany video. 

Here’s another. If you can find the q&a portion you’ll hear the $60m claim 
https://m.youtube.com/watch?v=ciFtOvIQy3I

I can’t be bothered looking further for that when there’s this....

“I could tell you between LATAM, this acquisition and the end of 2019 on a conservative basis we’re probably going to generate 50 million revenue minimum and I’m going to say 60 percent EBITA, not margin; EBITA, unheard of in this industry.”

https://midasletter.com/2018/07/video-aphria-inc-tseaph-ceo-vic-neufeld-on-global-cannabis-leadership/

:)
Firstly the that statement  says end of 2019.  We have several months to go.  Secondly ABP pharma does $11M USD a year in distribution income.  Jamaica last harvest was 2500KG.  With expected harvest to 5000 kg. Columbia is in a build out state which may or may not hit the end of 2019 but most likely will impact revenue in 2020. 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities